Additionally, Medicaid coverage of GLP-1 medications for obesity varies across states, leaving many patients ineligible for coverage depending on where they live
So far, researchers have found that people taking the daily 25 mg semaglutide pill lost an average of 16.6% of their body weight over about 64 weeks
For extended storage, aliquot reconstituted solution and freeze at 20 C (4 F)
Because there is no standard human therapeutic dose approved yet, usage in research contexts varies widely
Retatrutide is not indicated for children, females who are pregnant or planning to become pregnant, or females who are breastfeeding, due to insufficient long-term safety data
Bifidobacterium lactis Bi-07 Emerging evidence suggests Bi-07 can help reduce bloating and that overly full, pressure-y feeling GLP-1s sometimes create